123
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Relationship Between Fasting Blood Glucose Levels and First Ischemic Stroke in Elderly Hypertensive Patients

, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 777-784 | Published online: 12 Jul 2020

References

  • Li Z, Jiang Y, Li H, Xian Y, Wang Y. China’s response to the rising stroke burden. BMJ. 2019;364:l879. doi:10.1136/bmj.l87930819725
  • Wang W, Jiang B, Sun H, et al. Prevalence, Incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771. doi:10.1161/CIRCULATIONAHA.116.02525028052979
  • Wein T, Lindsay MP, Cote R, et al. Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2018;13(4):420–443. doi:10.1177/174749301774306229171361
  • Park C, Guallar E, Linton JA, et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care. 2013;36(7):1988–1993. doi:10.2337/dc12-157723404299
  • Baumert J, Heidemann C, Paprott R, Du Y, Scheidt-Nave C. Association between random glucose and all-cause mortality: findings from the mortality follow-up of the German National Health Interview and Examination Survey 1998. BMC Endocr Disord. 2018;18(1):95. doi:10.1186/s12902-018-0319-230545323
  • Lee G, Kim SM, Choi S, et al. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study. Cardiovasc Diabetol. 2018;17(1):51. doi:10.1186/s12933-018-0694-z29626936
  • Mongraw-Chaffin M, LaCroix AZ, Sears DD, et al. A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: the Women’s Health Initiative. Metabolism. 2017;70:116–124. doi:10.1016/j.metabol.2017.02.01028403935
  • Sung J, Song YM, Ebrahim S, Lawlor DA. Fasting blood glucose and the risk of stroke and myocardial infarction. Circulation. 2009;119(6):812–819. doi:10.1161/CIRCULATIONAHA.108.77698919188510
  • Sui X, Lavie CJ, Hooker SP, et al. A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men. Mayo Clin Proc. 2011;86(11):1042–1049. doi:10.4065/mcp.2011.026721911559
  • Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke. 2004;35(10):2351–2355. doi:10.1161/01.STR.0000140738.94047.5515308782
  • Shaye K, Amir T, Shlomo S, Yechezkel S. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J. 2012;164(1):111–116. doi:10.1016/j.ahj.2012.03.02322795290
  • Tziomalos K, Spanou M, Baltatzi M, et al. Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease. Diabetes Technol Ther. 2013;15(6):475–480. doi:10.1089/dia.2012.033623544673
  • Zhao R, Duan X, Wu Y, Zhang Q, Chen Y. Association of exposure to Chinese famine in early life with the incidence of hypertension in adulthood: A 22-year cohort study. Nutr Metab Cardiovasc Dis. 2019;29(11):1237–1244. doi:10.1016/j.numecd.2019.07.00831378624
  • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520. doi:10.1001/jama.2013.28442724352797
  • Association AD Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S00229222373
  • Xu RB, Kong X, Xu BP, et al. Longitudinal association between fasting blood glucose concentrations and first stroke in hypertensive adults in China: effect of folic acid intervention. Am J Clin Nutr. 2017;105(3):564–570. doi:10.3945/ajcn.116.14565628122783
  • Jin C, Li G, Rexrode KM, et al. Prospective study of fasting blood glucose and intracerebral hemorrhagic risk. Stroke. 2018;49(1):27–33. doi:10.1161/STROKEAHA.117.01918929229723
  • Doi Y, Ninomiya T, Hata J, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke. 2010;41(2):203–209. doi:10.1161/STROKEAHA.109.56470819940278
  • Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-920609967
  • Ohkubo T, Asayama K, Kikuya M, et al. Prediction of ischaemic and haemorrhagic stroke by self-measured blood pressure at home: the Ohasama study. Blood Press Monit. 2004;9(6):315–320. doi:10.1097/00126097-200412000-0000915564987
  • Lee JS, Chang PY, Zhang Y, et al. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: the Strong Heart Study. Diabetes Care. 2017;40(4):529–537. doi:10.2337/dc16-195828122840
  • Mitchell AB, Cole JW, McArdle PF, et al. Obesity increases risk of ischemic stroke in young adults. Stroke. 2015;46(6):1690–1692. doi:10.1161/STROKEAHA.115.00894025944320
  • Turner GM, Calvert M, Feltham MG, et al. Under-prescribing of prevention drugs and primary prevention of stroke and transient ischaemic attack in UK general practice: a retrospective analysis. PLoS Med. 2016;13(11):e1002169. doi:10.1371/journal.pmed.100216927846215
  • Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–3832. doi:10.1161/STR.000000000000004625355838
  • Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69(1):171–179. doi:10.1161/HYPERTENSIONAHA.116.0848527802419
  • Zhong P, Wu D, Ye X, et al. Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis. Drug Des Devel Ther. 2017;11:2517–2526. doi:10.2147/DDDT.S135785
  • Hankey GJ. Stroke. Lancet. 2017;389(10069):641–654. doi:10.1016/S0140-6736(16)30962-X27637676
  • Steiger N, Cifu AS. Primary Prevention of Stroke. JAMA. 2016;316(6):658–659. doi:10.1001/jama.2016.552927532921